Which patients are safest for simultaneous ridge augmentation and implant placement? Practical takeaways from a 391‑patient predictive analysis

A University of Michigan retrospective cohort quantifies postoperative sequelae, true complications and the clinical predictors that matter when you attempt simultaneous augmentation and implant placement.

Many practitioners choose to graft and place the implant in the same visit to save time and cost — but how often does that lead to trouble? A new retrospective cohort of 391 consecutive adults treated with alveolar ridge augmentation plus simultaneous implant placement (SARA) at a university periodontics clinic reports that postoperative sequelae (minor events such as prolonged swelling or temporary discomfort) happened in about 31.5% of sites, while true complications (events requiring further intervention) occurred in roughly 25.8%. Additional grafting at a later time was uncommon (about 6.1%). ([lifescience.net](

What most influenced those outcomes was not the number of systemic diseases per se but local defect morphology and surgical technique. Vertical or combined horizontal‑vertical defects carried higher odds of membrane exposure (adjusted OR 2.5), and the team found that microsurgical technique (gentle tissue handling, precise incisions and atraumatic suturing) reduced the risk of incision‑line dehiscence. Extending flaps increased the likelihood of prolonged swelling in proportion to the number of tooth sites reflected in the flap. ([lifescience.net](

Patient factors mattered mainly for the small group who later needed additional grafting. Current smokers had about five times the odds of requiring further grafting, adjacent teeth with advanced clinical attachment loss (CAL ≥5 mm) raised the odds strongly (OR ≈14), and long‑term systemic corticosteroid use was also associated with higher odds. The predictive model achieved reasonable discrimination (AUC 0.74), meaning the identified factors help stratify risk but do not perfectly predict every outcome. ([lifescience.net](

How to use this in everyday practice: first, measure and document defect morphology. If your CBCT or clinical assessment shows predominantly horizontal loss under the level of the adjacent ridge and no over‑contouring is necessary, simultaneous augmentation is reasonable for many patients and will avoid a second surgery for most. For vertical or combined defects, or where you must over‑contour beyond the neighbouring bone, plan a staged approach or counsel the patient about higher exposure risk. These recommendations are consistent with contemporary guidance on choosing simultaneous versus staged augmentation. ([onlinelibrary.wiley.com](

Surgical technique and simple perioperative choices make a measurable difference. Use microsurgical principles when possible: smaller, well‑planned flaps, tension‑free primary closure, careful papilla management and atraumatic suturing. Limit unnecessary flap extension — every extra tooth site reflected raised swelling risk — and be rigorous with debridement and control of any adjacent periodontal pockets before grafting. For smokers and patients on chronic steroids, factor the elevated risk of needing later augmentation into your treatment plan and consent. ([lifescience.net](

In short, expect minor sequelae in roughly one of three cases and a true complication in about one of four when you do SARA; expect later re‑grafting in about one in sixteen. The best way to lower those odds is careful case selection (avoid vertical/combined defects for simultaneous placement), correct soft‑tissue management using microsurgical technique, and addressing adjacent periodontal disease and smoking before you graft. The model in this paper can help structure informed consent and select patients more likely to have an uncomplicated course, but remember models are guides not guarantees. ([lifescience.net](